ArticleResearch square2025
Predictors of Metabolic Dysfunction-Associated Steatotic Liver Diseases (MALSD) in Vietnamese Population.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
17 authors.
Funding
Abstract
Background and Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) comprises a spectrum of liver diseases from simple steatosis, non-alcoholic steatohepatitis (NASH) which progresses to fibrosis and compensated cirrhosis. Worldwide, MASLD significantly contributes to the rising incidence of liver cancer. Lille is known about its predictors in Asian population and particularly among Vietnamese. Approach and Results: We determine the predictors of MASLD in Vietnamese population using a hospital-based case-control study of 100 MASLD patients and 119 healthy controls. Unconditional logistic regression model was used to calculate odds ratios (ORs) and respective 95% confidence intervals (CIs) for MASLD in relation to potential predictors. Overall, body mass index (BMI) (OR Conclusions: Besides clinical factors such as BMI, diabetes, AST, and GGT, liver stiffness measurement (i.e., kPA and CAP score) played important roles as predictors for MALSD in Vietnamese population. Our findings, for the first time, provided evidence for risk stratification and treatment management of MALSD in Vietnamese population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.